DD vs PFE · P/E 127, rev $12.39B vs P/E 20, rev $62.58B
Dupont De Nemours Inc (DD) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
DD currently screens at market cap $19.61B and trailing P/E 127.4. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the DD and PFE stock pages for the full models.
Not investment advice.